Maureen Newman is a science columnist for Pulmonary Hypertension News. She is currently a PhD student studying biomedical engineering at University of Rochester, working towards a career of research in biomaterials for drug delivery and regenerative medicine. She is an integral part of Dr. Danielle Benoit's laboratory, where she is investigating bone-homing therapeutics for osteoporosis treatment.
Breast cancer is a problem best solved by a multidisciplinary team. As such, a collaboration between biologists, physicists, and engineers at Georgetown Lombardi Comprehensive Cancer Center and Virginia Tech have ... Read more
Researchers at the University of California, Los Angeles (UCLA) have harnessed the power of large and expensive microscopes for cancer detection into the world’s first lens-free microscope. The device ... Read more
Certain common DNA variations, called polymorphisms, can determine how tumor progression evolves in breast cancer and other types of cancers, including ovarian cancer. Researchers at The Wistar Institute, led ... Read more
An experimental drug known as palbociclib, developed by Pfizer, Inc. and tested at the Revlon/UCLA Women’s Cancer Research Program in UCLA’s Jonsson Comprehensive Cancer Center (JCCC), extended progression-free survival ... Read more
Despite clinical recommendations against using Cytochrome P450 2D6 (CYP2D6) gene expression as a guide for tamoxifen therapy for breast cancer patients, a study from the Mayo Clinic suggests otherwise. ... Read more
Despite the utility of certain biomarkers in predicting triple negative breast cancer outcomes after chemotherapy treatment, it appears as though the level of tumor-infiltrating lymphocytes (S-TILs) cannot predict the ... Read more